| Trial ID: | L2914 |
| Source ID: | NCT01071772
|
| Associated Drug: |
Insulin
|
| Title: |
The Effect of Hyperglycemia on LV Function and Exercise Capacity in Diabetics With and Without Heart Failure.
|
| Acronym: |
METAMOD
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Heart Failure|Type 2 Diabetes
|
| Interventions: |
DRUG: insulin
|
| Outcome Measures: |
Primary: 1: Cardiac systolic (EF by 2D and 3D echocardiography) and diastolic (e´/E and E/A) function before and after exercise., 1-4 weeks|Exercise capacity, 1-4 months | Secondary: Regional left ventricular function before and after maximum exercise(regional 2D tissue velocity and strain), 1-4 weeks
|
| Sponsor/Collaborators: |
Sponsor: University of Aarhus | Collaborators: Danish Heart Foundation|Region midtjyllands sundhedsvidenskabelige forskningsfond
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
18
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2009-04
|
| Completion Date: |
2010-07
|
| Results First Posted: |
|
| Last Update Posted: |
2011-06-09
|
| Locations: |
Department ofCardiology, Aarhus University Hospital, Skejby, Aarhus, Region Midtjylland, 8200, Denmark
|
| URL: |
https://clinicaltrials.gov/show/NCT01071772
|
